Storage, Handling & Disposal of Substances
Federal requirements for storage, handling, and disposal of non-hazardous, hazardous (e.g., P-list), and pharmacological substances and wastes.
Storage, Handling & Disposal of Substances is worth 3.2% of the PTCE and sits inside the Federal Requirements domain (18.75% overall). It tests how controlled substances, hazardous drugs, and pharmaceutical wastes must be physically secured, handled, and destroyed under DEA, EPA (RCRA), and USP standards. The core principle: the tighter the abuse or hazard potential, the tighter the storage and destruction rule — and "throw it in the trash or down the drain" is almost never a legal answer.
Controlled Substance Storage — 21 CFR 1301.75
Under 21 CFR 1301.75, Schedule I substances must be stored in a securely locked, substantially constructed cabinet. Schedules II through V may also be stored in such a cabinet, but pharmacies and institutional practitioners are permitted to disperse those substances throughout the stock of non-controlled drugs in a way that obstructs theft or diversion. Above this specific rule sits 21 CFR 1301.71, a general obligation that every registrant maintain security controls "adequate to provide effective controls against theft and diversion," which the DEA field office can hold to a higher standard based on a facility's risk.
The locked-cabinet-or-disperse option under 1301.75(b) applies to Schedules II through V — not just Schedule II.
RCRA Hazardous Waste and the P-List
The EPA's Resource Conservation and Recovery Act (RCRA) classifies discarded drugs as hazardous waste. The P-list (40 CFR 261.33) is acutely hazardous waste — the strictest category, where even container residue counts. Classic pharmacy P-listed examples: warfarin as sole active ingredient (P001) when discarded at concentrations above 0.3% (below that it drops to the U-list, U248), physostigmine (P204), and nicotine (P075). The U-list covers toxic (non-acute) discarded commercial chemical products. In 2019 the EPA amended the P075 nicotine listing to exempt FDA-approved OTC nicotine replacement patches, gums, and lozenges, and removed epinephrine (and epinephrine salts) as the sole active ingredient from hazardous-waste management when discarded.
P-list = acutely hazardous; the residue in an "empty" P-listed container is still regulated waste.
Subpart P and Never Sewering Hazardous Drugs
The EPA Management Standards for Hazardous Waste Pharmaceuticals (40 CFR Part 266, Subpart P) govern healthcare facilities and reverse distributors. A key prohibition: hazardous waste pharmaceuticals may not be flushed down a drain or toilet (no "sewering"). Under Subpart P a facility may accumulate hazardous waste pharmaceuticals on site for up to 365 days, and those pharmaceuticals do not count toward the facility's monthly generator status. USP General Chapter 800 layers on handling of NIOSH-listed hazardous drugs — storage in an externally vented, negative-pressure room (at least 12 air changes per hour), unpacking away from sterile compounding areas, and PPE such as two pairs of chemotherapy-tested gloves and a protective gown.
Disposal and Destruction of Controlled Substances
Controlled substances in a pharmacy's stock that must be destroyed are recorded on DEA Form 41 and rendered "non-retrievable" per 21 CFR Part 1317 — a standard that permanently alters the drug's physical or chemical condition so it cannot be reconstituted. Registrants commonly ship stock to a reverse distributor for destruction. Non-hazardous, non-controlled pharmaceutical waste follows general medical/pharmaceutical waste rules, while hazardous drugs must be segregated for a licensed hazardous-waste hauler and manifested — never mixed into ordinary trash.
DEA destruction of controlled substances must meet the "non-retrievable" standard and be documented on DEA Form 41.
Must-Know for the Exam
- ✓Schedule I: securely locked, substantially constructed cabinet only
- ✓Schedules II–V: locked cabinet OR dispersed throughout non-controlled stock (pharmacies)
- ✓P-list = acutely hazardous waste (RCRA); U-list = toxic non-acute waste
- ✓Warfarin (sole active) is P001 above 0.3% concentration, U248 at/below 0.3%
- ✓Hazardous waste pharmaceuticals may never be sewered (drain/toilet disposal is prohibited)
- ✓USP <800>: NIOSH-listed hazardous drugs stored in negative-pressure room, ≥12 air changes/hour
- ✓Controlled substance destruction uses DEA Form 41 and the "non-retrievable" standard
- ✓Subpart P allows 365-day on-site accumulation of hazardous waste pharmaceuticals
Common Exam Mistakes
- ✗Thinking the 1301.75 disperse-in-stock allowance is limited to Schedule II
- ✗Flushing hazardous waste pharmaceuticals down the drain
- ✗Treating an "empty" P-listed container as ordinary trash — residue is still acute hazardous waste
- ✗Confusing the P-list (acute) with the U-list (toxic, non-acute)
- ✗Assuming epinephrine or OTC nicotine patches are still full RCRA hazardous waste after the 2019 EPA amendments
Quiz yourself on Storage, Handling & Disposal of Substances
Test what you just read — instant feedback on every question.
Start Storage, Handling & Disposal of Substances Practice Quiz →Key Concepts — Part 1
1. Under DEA regulations, a retail pharmacy may store its Schedule II controlled substance stock in which of the following ways?
In a securely locked cabinet of substantial construction, or dispersed throughout the non-controlled stock to reduce the likelihood of theft
DEA regulations allow Schedule II substances to be stored in a securely locked cabinet of substantial construction or dispersed among the pharmacy's other stock in a manner designed to obstruct theft. A is too narrow, since a safe is only one option. C fails because an unlocked cabinet does not meet the security standard even with cameras. B confuses schedule-based storage security with mere labeling, which is not the controlling federal requirement.
2. How often must a pharmacy conduct a complete, physical inventory of all controlled substances on hand, per DEA requirements?
Every 2 years (biennially)
DEA requires a biennial (every two years) inventory of all controlled substances. Quarterly (A) and annual (B) are more frequent than federal law requires. A change in pharmacist-in-charge (D) does not by itself trigger a mandatory new federal inventory, though many employers have their own change-of-pharmacist policies.
3. During the biennial inventory, how must Schedule II controlled substances be counted?
Exact count or measure of the contents
Schedule II substances must always be counted exactly, regardless of container size or whether the seal is broken. A describes the estimated method allowed only for certain Schedule III-V stock. C and D are not accurate descriptions of the federal counting standard for Schedule II.
4. For Schedule III, IV, and V substances, when may a pharmacy use an estimated count during inventory instead of an exact count?
When the container holds fewer than 1,000 dosage units and the seal has not been broken
Federal rules (21 CFR 1304.11(e)) permit an estimated count for Schedule III-V stock only when the container is unopened AND holds 1,000 dosage units or fewer. An exact count is required once a container has been opened AND holds more than 1,000 units. A incorrectly extends the Schedule II exact-count rule to III-V. C and D are not the governing federal criteria.
5. Which DEA form is used to document the destruction of unwanted or expired controlled substances?
DEA Form 41
DEA Form 41 documents the surrender and destruction of controlled substances. Form 222 (A) is used to order Schedule I and II drugs. Form 106 (B) reports theft or significant loss. Form 224 (C) is the pharmacy's initial DEA registration application.
6. What is the primary role of a DEA-registered reverse distributor?
Receiving and properly disposing of or returning unwanted, expired, or damaged controlled substances from a registrant
A reverse distributor is DEA-registered to accept expired, damaged, or unwanted controlled substances from a pharmacy for proper return to manufacturers or destruction. Reverse distributors do not dispense to patients (A), fill prescriptions (C), or issue DEA registrations (D), which is the DEA's own function.
7. A pharmacy technician is sorting expired pharmaceutical waste and finds a partially used vial of physostigmine, a drug on the EPA's P-list. How should this waste be handled?
Managed as acute hazardous waste, kept separate from other pharmaceutical waste and never poured down a drain
P-listed drugs are classified by the EPA as acute hazardous waste and must be segregated and disposed of through a hazardous waste program, never poured down a drain or discarded with ordinary trash. Sewer disposal (A) and ordinary trash (B) violate hazardous waste rules, and returning hazardous waste to a patient (D) is never appropriate.
8. Which of the following best describes the non-retrievable standard the DEA applies to controlled substance destruction?
Rendering the controlled substance unavailable and unusable for all practical purposes, with no reasonable expectation of recovery or reuse
The DEA defines non-retrievable destruction as permanently altering a controlled substance's physical or chemical condition so it is beyond recovery or reuse. Locking it away (A) does not destroy it. Returning to a manufacturer (C) is a return, not destruction. Flushing (B) is discouraged for most drugs and does not meet the non-retrievable standard for most controlled substances.
9. A pharmacy wants to let patients drop off unused controlled substance medications for disposal year-round, not just on a designated take-back day. What must the pharmacy do to legally operate an ongoing collection receptacle?
Register with the DEA as an authorized collector
Under the Secure and Responsible Drug Disposal Act, a pharmacy must register with the DEA as an authorized collector to maintain an ongoing collection receptacle for patient-returned controlled substances. Pharmacies cannot simply accept controlled substances back informally (A); the requirement is not tied to individual technician licensure (C) or limited to Schedule V drugs (D).
10. DEA National Prescription Drug Take-Back Day allows the public to do which of the following?
Anonymously and safely dispose of unused or expired prescription medications, including controlled substances, at designated collection sites
Take-Back Day is a periodic DEA-sponsored event offering the public free, anonymous disposal of unused medications. It does not involve reimbursement (A), does not affect prescription refill rules (C), and is a disposal event, not a diversion-reporting mechanism (D).
Key Concepts — Part 2
1. When must a pharmacy conduct its initial inventory of controlled substances?
On the date the pharmacy first engages in controlled substance activity under its DEA registration
Federal law requires an initial inventory on the date a pharmacy first begins handling controlled substances under its DEA registration, establishing the baseline for future biennial inventories. It is a federal requirement independent of state board request (A), unrelated to individual hiring events (B), and D is incorrect since an initial inventory is mandatory.
2. A technician notices hazardous chemotherapy waste placed in the same disposal bin as ordinary expired vitamins. Why is this improper?
Chemotherapy waste and non-hazardous pharmaceutical waste have different federal disposal requirements and must not be commingled
Hazardous pharmaceutical waste, including many chemotherapy agents, is subject to separate handling and disposal requirements from ordinary non-hazardous waste like vitamins, and commingling them violates hazardous waste rules. B and C misstate basic classification, and D is not a proper disposal method.
3. A pharmacy is closing permanently. What must it do with its remaining controlled substance inventory under federal law?
Transfer it to a DEA-registered entity authorized to receive it, such as another registrant or a reverse distributor, and notify the DEA
A closing pharmacy must properly transfer its controlled substance stock to another DEA registrant authorized to receive it, or to a reverse distributor, and notify the DEA of the closure and disposition. Discarding in trash (A) and giving drugs to employees (C) are diversion and illegal; indefinite unmonitored storage (D) does not satisfy disposition requirements.
4. Which statement about witnessing the on-site destruction of controlled substances documented on DEA Form 41 is correct?
Typically two individuals, generally including someone authorized by the registrant, witness and sign to document the destruction
Proper documentation of on-site destruction typically requires two witnesses to sign Form 41, providing accountability. A single technician acting alone (A) does not meet this standard, the requirement is not limited to Schedule I (B), and cameras do not substitute for required witness documentation (D).
5. A pharmacy stores its Schedule III-V stock mixed together on open shelving, separate from Schedule II. Which statement reflects federal storage expectations?
All controlled substances, including III-V, must still be maintained with effective controls against theft and diversion — the locked-cabinet-or-dispersal rule applies to Schedules II, III, IV, and V alike
Per 21 CFR 1301.75(b), the locked-cabinet-or-dispersal requirement applies equally to Schedules II, III, IV, and V — it is not a Schedule-II-only rule. A and C incorrectly claim no obligation exists for III-V, and B describes an unsafe, noncompliant practice.
6. A technician finds a discrepancy during a routine controlled substance count that suggests a possible loss. What is the technician's most appropriate first action?
Report the discrepancy immediately to the pharmacist-in-charge
A technician who identifies a possible loss must promptly escalate to the pharmacist-in-charge, who determines whether the discrepancy is significant and must be reported to the DEA. Silently adjusting records (A) is falsification, waiting (C) risks continued diversion going undetected, and destroying stock (B) destroys evidence and is not authorized.
Ready to test your knowledge?
Practice questions with instant feedback and explanations.
Take a PTCB Practice Test →